ความชุกของภาวะตับคั่งไขมันชนิดที่ไม่ได้เกิดจากการดื่มแอลกอฮอล์ในข้าราชการตำรวจ โดยการใช้เครื่อง Controlled Attenuation Parameter with Transient Elastography

Nantarat  Bunyarat

Authors

Nantarat Bunyarat Department of Family Medicine, Police General Hospital

Keywords:

non-alcoholic fatty liver disease (NAFLD), controlled attenuation parameter with transient elastography (CAP-TE)

Abstract

The purposes of this research were to examine 1) the prevalence of non-alcoholic fatty liver disease (NAFLD) and 2) factors associated with NAFLD in Thai policemen. Samples were two hundred and eighty-seven policemen aged from 18 to 60 years. Questionnaires were composed of demographic data and health data, which passed IOC from three qualified specialists with a score of .67-1.00. Steatosis and fibrosis levels were measured by CAP-TE. Data were analyzed using descriptive statistics, Pearson’s correlation coefficients, Chi-squared test, and logistic regressions.

The major findings were as follows: 1) 170 out of 287 participants were found to have steatosis of S1-S3 stage, which the calculated prevalence of NAFLD in policemen in this study was 59.23%; 2) Factors associated with a higher incidence of NAFLD were gender (male), age (36-60 years old), BMI (> 23 kg/m²), underlying disease (hypertension), waist circumference (> 80 cm. in females and > 90 cm. in males), Triglycerides, LDL, FBS, Alt (higher level) and HDL (lower level), systolic blood pressure (SBP > 140 mmHg), and diastolic blood pressure (DBP > 90 mmHg) (p < .05); 3) Causes of NAFLD were triglycerides level (OR = 1.01, 95%CI = 1.001-1.018, p = .025), BMI (OR = 1.20, 95%CI = 1.022-1.419, p = .026), and waist circumference (OR = 1.08, 95%CI = 1.016-1.153, p = .014).

Thus, we found that it was necessary to screen for NAFLD and metabolic syndrome during an annual check-up in policemen to reduce morbidity and mortality from NAFLD and associated diseases.

Downloads

Download data is not yet available.

References

Abeysekera, K. W. M., Fernandes, G. S., Hammerton, G., Portal, A. J., Gordon, F. H., Heron, J., & Hickman, M. (2020). Prevalence of steatosis and fibrosis in young adults in the UK: A population-based study. Lancet Gastroenteral Hepatology, 5(3), 295-305.

Albhaisi, S., Chowdhury, A., & Sanyal, A. J. (2019). Non-alcoholic fatty liver disease in lean individuals. Journal of Hepatology, 1(4), 329-341. https://doi.org/10.1016/j.jhepr.2019.08.002

Anchalee, N., & Muktabhant, B. (2020). Lifestyle an personal characteristic factors associated with overnutritional status among supporting staff of Khon Kaen university. Srinagarind Medical Journal, 35(1), 89-97.

Castera, L., Friedrich-Rust, M., & Loomba, R. (2019). Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology, 156, 1264-1281.

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357. https://doi.org/10.1002/hep.29367

Doycheva, I., Watt, K. D., & Alkhouri, N. (2017). Nonalcoholic Fatty liver disease in adolescents and young adults: The next frontier in the epidemic. Hepatology, 65(6), 2100-2109. https://doi.org/10.1002/hep.29068

Gallacher, J., & McPherson, S. (2018). Practical diagnosis and staging of nonalcoholic fatty liver disease: A narrative review. European Medical Journal, 3(2), 108-118.

Hashemi, S. A., Alavian, S. M., & Fesharaki, M. G. (2016). Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Caspian Journal of Internal Medicine, 7(4), 242-252.

Khamchata, L., Dumrongpakapakorn, P., & Theeranut, A. (2018). Metabolic syndrome: Dangerous signs required management. Srinagarind Medical Journal, 33(4), 386-395.

Kwak, M. S., Chung, G. E., Yang, J. I., Yim, J. Y., Chung, S. J., Jung, S. Y., & Kim, J. S. (2018). Clinical implications of controlled attenuation parameter in a health check-up cohort. Liver International, 38(5), 915-923. https://doi.org/10.1111/liv.13558

Okur, G., & Karacaer, Z. (2016). The prevalence of non-alcoholic fatty liver disease in healthy young persons. Northern Clinics of Istanbul, 3(2), 111-117. https://www.doi.org/10.14744/nci.2016.28199

Ponciano-Rodriguez, G., & Mendez-Sanchez, N. (2010). Cigarette smoking and fatty liver. Annals of Hepatology, 9(2), 215-218.

Teeratorn, N., Piyachaturawat, P., Thanapirom, K., Chaiteerakij, R., Sonsiri, K., Komolmit, P., . . . Treeprasertsuk, S. (2019). Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography. Journal of Gastroenterology and Hepatology (JGH Open), 4(2), 245-250. https://www.doi.org/10.1002/jgh3.12252

Than, N. N., & Newsome, P. N. (2015). A concise review of non-alcoholic fatty liver disease. Atherosclerosis, 239, 192-202.

Vanduangden, K., Chaiteerakij, R., Thanapirom, K., Sonsiri, K., & Treeprasertsuk, S. (2017). Prevalence of nonalcoholic fatty liver disease (NAFLD) diagnosed by controlled attenuation parameter with transient elastography in subjects with and without metabolic syndrome. Chulalongkorn Medical Journal, 61(4), 483-495.

Yotongyos, M., & Swasdison, P. (2014). Determining sample size for research. Nakhon Ratchasima: Academic Service Centre Institute for Promotion of Research and Innovation Development Fort Suranari Hospital.